Detalhe da pesquisa
1.
The immunological contribution to heterotopic ossification disorders.
Curr Osteoporos Rep
; 13(2): 116-24, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25687936
2.
Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1R206H Mouse Model of Fibrodysplasia Ossificans Progressiva.
J Bone Miner Res
; 33(2): 269-282, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28986986
3.
Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
J Bone Miner Res
; 31(9): 1666-75, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26896819
4.
Reply to: Macrophages Driving Heterotopic Ossification: Convergence of Genetically-Driven and Trauma-Driven Mechanisms.
J Bone Miner Res
; 33(2): 367-368, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29194751
5.
An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva.
J Bone Miner Res
; 27(8): 1746-56, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22508565